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duce chondrogenesis in limb bud mesemchyme, whereas murine
NFATc2 (NFATp) likely acts as a repressor of cartilage formation,
since NFATc2 knock-out mice showed extra-articular cartilage
formation.
These data suggest that the Cn-NFAT signaling plays an impor-
tant role in embryonic chondrogenesis, and despite the recently
reported involvement of Cn in the progression of osteoarthri-
tis, still virtually nothing is known about Cn and NFATs in the
phenotypical regulation of adult human articular chondrocytes.
The aim of this study was to evaluate the role of Cn-NFAT
signaling during phenotype development of adult human articular
chondrocytes in vitro.
Methods: Cn activity was monitored in in-vitro monolayer cul-
tured primary (Passage 0, P0) and dedifferentiated (P1-P3) chon-
drocytes and in 3D-cultured redifferentiated chondrocytes. To
study the regulation of the Cn-NFAT pathway, gene expression
of NFATc1-c4 and of the catalytic Cn subunit (CnA) isoforms
α, β and γ was measured. Gene expression of collagen type II
(COL2) and type I (COL1), SOX9 and aggrecan (AGC1) was
studied as chondrogenic markers, and that of collagen type X
(COL10) and matrix metalloproteinase 13 (MMP 13) as indicators
of chondrocyte hypertrophy. In addition, the short- and long-term
effects of the Cn inhibitor FK506 on chondrocyte phenotype were
determined.
Results: Cn activity increased during chondrocyte dedifferen-
tiation, and decreased after redifferentiation. NFATc4 gene ex-
pression also increased during dedifferentiation and decreased
during redifferentiation, whereas NFATc2 showed the opposite
trend. The expression of NFATc1, NFATc3 and all CnA isoforms
was not signiﬁcantly regulated during chondrocyte differentiation.
Addition of FK506 decreased Cn activity and resulted in a more
chondrogenic phenotype, with increased COL2 and decreased
MMP13 expression. This was accompanied by increased NFATc2
and decreased NFATc4 levels.
Conclusions: These results suggest a regulating role for Cn-
NFAT signaling in chondrogenic differentiation of articular chon-
drocytes in vitro. Inhibition of this pathway with FK506 restored
a proper chondrogenic phenotype. Therefore, FK506 might be
useful to facilitate chondrocyte in-vitro expansion for cartilage
tissue engineering purposes and other cell-based therapies, or
for in-vivo application to enhance the repair of focal chondral le-
sions. Our results might also explain how calcineurin is involved
in the progression of osteoarthritis, by driving chondrocyte dedif-
ferentiation.
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Purpose: The transcription factor Sox9 is a key molecule in
early chondrogenesis. Despite its important function as a master
regulator of chondrogenic differentiation little is known about
Sox9 gene regulation, redundancies among Sox family genes,
effects of expression level and the direct and indirect impact
of Sox9 on differentiation stage speciﬁc processes. Literature
shows that Sox9 knockout mice, due to postnatal morbidity, fail
to reveal detailed insights into the regulatory functions of Sox9.
Thus more elaborate techniques for the explicit analysis of Sox9
have to be developed. We have employed RNA interference
(RNAi) to study the effects of Sox9 gene knock down in an in
vitro model system. Here we present proof of principle pilot study
on murine ﬁbroblast cell line NIH3T3.
Methods: Cells were cultured in monolayer and upon reaching
45% conﬂuence they were transduced with Sox9 shRNA by using
Clonetech™’s pSIREN viral transduction system. Transduction
efﬁciency was evaluated after 48-72 hours by analyzing the
gene expression level of Sox9 normalized to endogenous ß-actin
using quantitative PCR. Knockdown level of Sox9 protein was
determined by western blotting with Sox9 speciﬁc antibody.
Results: An average of 80% knockdown of Sox9 was observed
compared to control cells which were transduced with luciferase
shRNA. Nearly 100% absence of Sox9 protein conﬁrmed the
knockdown effect. Downstream effects of the Sox9 silencing were
analysed and relative mRNA expression of three transcription
factors, Sox4, Sox6 and Tbox2 was evaluated and compared
with control cells. The results showed a clear down regulation
of Sox6 while Tbox2 (1.4 folds) and Sox4 (1.8 folds) were non-
signiﬁcantly increased and thus appeared relatively unaffected
by the absence of Sox9. Housekeeping protein ß-actin remained
unaffected indicating Sox9 gene silencing to be speciﬁc and
not due to RNAi provoked unspeciﬁc silencing or viral interferon
mediated “off target” mechanism. Decreased gene expression
of Sox6, known to be active downstream of Sox9, validated
gene silencing together with unaffected Sox4 and Tbox2 mRNA
expression level.
Conclusions: With this pilot in vitro gene silencing study we
conclusively show that the Sox9 gene can be knocked down up to
satisfactory levels by using the plasmid based gene transduction
system.
It serves as a foundation for Sox9 knock down study in primary
mesenchymal stem cells to identify hitherto unknown signalling
factors, redundant genes and unidentiﬁed genes involved in
chondrogenesis and maintenance of a stable chondrogenic phe-
notype in adult cells.
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Purpose: The Osteoarthritis Initiative (OAI) is a multi-center,
prospective cohort study targeted at identifying the most sensitive
biomarkers for evaluating the progression of symptomatic knee
OA. We have developed an MR-based technique for determining
cartilage thickness in anatomically deﬁned subregions that can
be varied in size. Here we analyze 12 month longitudinal MRI
data from a subset of the OAI, to examine which subregions (and
which choices in subregion size) are most sensitive to changes
in cartilage thickness.
Methods: An age and gender stratiﬁed subsample of the OAI
progression subcohort (n = 156, 79 women, 77 men, age 60.9 ±
9.9 y., BMI 30.3 ± 4.7) with frequent symptoms and radiographic
OA in at least one knee was studied (OAI public-use datasets
0.1.1, 0.B.1 & 1.B.1). K/L grade 2/3 knees in obese (BMI >30)
persons were selected as a subgroup at high risk for progression
(n=54). 1.5mm coronal FLASHwe MR images of all right knees
were acquired using 3T Siemens scanners. 7 experienced read-
ers segmented medial/lateral tibial (MT/LT) and medial/lateral
weight-bearing femoral (cMF/cLF) cartilages blinded to order of
